Safety, Pharmacokinetics, and Efficacy of Subcutaneous Isatuximab in Adults With Warm Autoimmune Hemolytic Anemia (wAIHA)
Clinical trial NCT04661033 · TERMINATED
Trial details
- NCT number
- NCT04661033
- Sponsor
- Sanofi
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-09
- Primary completion
- 2023-06-26
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.